By using this miR-143, we were able to unveil the networks of RAS-signaling pathways and the oncogenic roles of K-RAS and H-RAS in BC cells, and we showed the possibility that the novel synthetic miR-143 would be applied to early BC by intravesical infusion. This evidence concerns the gene KRAS and breast cancer.